FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Schuler Family Foundation 		2. Issuer Name and Ticker or Trading Symbol

HANSEN MEDICAL INC [ HNSN ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

28161 N. KEITH DRIVE 		3. Date of Earliest Transaction (MM/DD/YYYY)

7/30/2014
(Street)

LAKE FOREST, IL 60045
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant (Right to Buy Common Stock)   $1.50   7/30/2014     D         3744094    8/8/2013   8/8/2015   Common Stock   3744094     (1) 0   D    
Warrant (Right to Buy Common Stock)   $2.00   7/30/2014     D         3744094    8/8/2013   8/8/2015   Common Stock   3744094     (1) 0   D    
Warrant (Right to Buy Common Stock)   $1.13   7/30/2014     A      7488188         (2)   (3) Common Stock   7488188     (1) 7488188   D    
Warrant (Right to Buy Common Stock)   $1.13   7/30/2014     A      2302618         (2)   (4) Common Stock   2302618     (1) 2302618   D    

Explanation of Responses:
( 1)  The reporting person and the issuer entered into an Exchange Agreement dated July 30, 2014 (the "Exchange Agreement") pursuant to which the issuer will cancel outstanding warrants with $1.50 per share and $2.00 per share exercise prices in exchange for the issuance of new warrants with $1.13 per share exercise prices and the reporting person's agreement to exercise a portion of the new warrants within fourteen days of the Issuance Date (as defined below).
( 2)  The warrant shall be exercisable at any time after the date of issuance of the warrant, which shall be the closing date of the exchange of warrants pursuant to the Exchange Agreement (the "Issuance Date").
( 3)  The date that is fourteen days following the Issuance Date.
( 4)  The date that is five years following the Issuance Date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Schuler Family Foundation
28161 N. KEITH DRIVE
LAKE FOREST, IL 60045
X


Signatures
/s/ Jack Schuler, Director 8/1/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Hansen Medical, Inc. (MM) 차트를 더 보려면 여기를 클릭.
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Hansen Medical, Inc. (MM) 차트를 더 보려면 여기를 클릭.